Christopher M. Booth
Queen's University · 468 works · 14,209 citations · h-index 57
Top works
- Clinical Features and Short-term Outcomes of 144 Patients With SARS in the Greater Toronto Area
- Is This Patient Dead, Vegetative, or Severely Neurologically Impaired?
- Association Between Time to Initiation of Adjuvant Chemotherapy and Survival in Colorectal Cancer
- Cancer, COVID-19 and the precautionary principle: prioritizing treatment during a global pandemic
- Randomised controlled trials and population-based observational research: partners in the evolution of medical evidence
- Progression-Free Survival: Meaningful or Simply Measurable?
- Evolution of the Randomized Controlled Trial in Oncology Over Three Decades
- The impact of socioeconomic status on stage of cancer at diagnosis and survival
- Design characteristics, risk of bias, and reporting of randomised controlled trials supporting approvals of cancer drugs by European Medicines Agency, 2014-16: cross sectional analysis
- Real-world data: towards achieving the achievable in cancer care
- Does This Patient With Headache Have a Migraine or Need Neuroimaging?
- Evolution of the Randomized Clinical Trial in the Era of Precision Oncology
- Guideline on Muscle-Invasive and Metastatic Bladder Cancer (European Association of Urology Guideline): American Society of Clinical Oncology Clinical Practice Guideline Endorsement
- Delivery of meaningful cancer care: a retrospective cohort study assessing cost and benefit with the ASCO and ESMO frameworks
- An Analysis of Contemporary Oncology Randomized Clinical Trials From Low/Middle-Income vs High-Income Countries
- Severe acute respiratory syndrome and critical care medicine: The Toronto experience
- Access to cancer medicines deemed essential by oncologists in 82 countries: an international, cross-sectional survey
- The Colon Health and Life-Long Exercise Change Trial: A Randomized Trial of the National Cancer Institute of Canada Clinical Trials Group
- Do Contemporary Randomized Controlled Trials Meet ESMO Thresholds for Meaningful Clinical Benefit?
- Randomized controlled trials in the era of molecular oncology: methodology, biomarkers, and end points